pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
sniff results

“Pfizer”

742 total hits · 12 drugs · 2 companies · 0 diseases · 670 catalysts · 58 news

Drugs(12)

expand →
Marketed
Aminophylline Pfizer
Aminophylline · aminophylline [INN]
Asthma
Marketed
Bleomycin Sulfate Pfizer
Bleomycin Sulfate · bleomycin sulfate
Cervical Cancer
Marketed
Bortezomib Pfizer
Bortezomib · bortezomib
Mantle Cell Lymphoma
Marketed
Carboplatin Pfizer
Carboplatin · carboplatin
Metastatic Ovarian Cancer
Marketed
Cytarabine Pfizer
Cytarabine · cytarabine
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)
Marketed
Dobutamine Hydrochloride Pfizer
Dobutamine Hydrochloride · dobutamine hydrochloride
Congestive Heart Failure (Heart Failure)
Marketed
Furosemide Pfizer
Furosemide · furosemide
Hepatic Edema
Marketed
Gentamicin Sulfate Pfizer
Gentamicin Sulfate · gentamicin sulfate
Bacterial Respiratory Tract Infections
view all 12 drug results →

🐶 Companies(2)

expand →
  • PFIZER
  • $PFEPFIZER INC

Catalysts(670)

expand →
view all 670 catalyst results →

News(58)

expand →
  • Trailing rivals, AbbVie scores win with dual-acting myeloma drug↗
    The drugmaker is leaning on a better side effect profile compared to drugs from J&J, Pfizer and Regeneron as it pushes etentamig toward FDA submission.
    biopharma dive · 2d ago
  • STAT+: We’re reading about a Bristol CAR-T trial pause, Pfizer offloading a shelved candidate, and more↗
    The latest pharma news from the Pharmalot campus brought to you by the Pharmalittle newsletter
    stat · 2d ago
  • Ionis’ rare neurology drug approved; Pfizer inks an ADC deal↗
    Zanvastro is now the first approved medicine for Alexander disease. Elsewhere, an immune system specialist posted positive results and a cell therapy developer turned to layoffs.
    biopharma dive · 2d ago
Pfizer punts Seagen ADC, further muddying value of the $43B buyout↗
The co-development deal comes after Pfizer reported a late-stage failure for a Seagen asset and the discontinuation of another investigational therapy developed by the company as a subsidiary of th…
biospace · 2d ago
  • Pfizer shares ADC rights with Medicus; RevMed updates lung cancer data↗
    Plus, news about Novartis. 🤝 Pfizer turns over ADC: The New York pharma is giving Medicus Pharma co-development rights to a CD228-targeted antibody-drug conjugate known as PF-08046031, a Seagen-de…
    endpoints · 3d ago
  • Pfizer offloads scrapped Seagen ADC to Medicus Pharma in up to $1B+ deal↗
    Pfizer has found a new home for an antibody-drug conjugate it acquired in its $43 billion Seagen buyout and dropped earlier this year.
    fiercebiotech · 3d ago
  • FDA green lights Priovant drug for rare skin disease↗
    Lisraya’s clearance marks the first approval of a drug the Roivant subsidiary licensed from Pfizer and has since positioned against multiple rare inflammatory conditions.
    biopharma dive · 9d ago
  • #ESC26: Trial failure clouds future of AstraZeneca’s heart disease gene silencer↗
    MUNICH — The surprise failure of a high-profile study of AstraZeneca and Ionis Pharmaceuticals’ Wainua can be attributed to patients in the trial also taking a Pfizer drug for the same condition, t…
    endpoints · 9d ago
  • view all 58 news results →
    Nov 3, 2026
    earnings
    in 2mo
    PFIZER INC earnings
    PFIZER INC
    →
    Aug 4, 2026
    8k filing
    1mo ago
    $PFE — PFIZER INC (PFE) — 8-K filing
    →
    Aug 4, 2026
    earnings
    1mo ago
    PFIZER INC earnings
    PFIZER INC
    →
    Jul 29, 2026
    earnings
    1mo ago
    PFIZER INC earnings
    PFIZER INC
    →
    Jun 18, 2026
    8k filing
    3mo ago
    $PFE — PFIZER INC (PFE) — 8-K filing
    →
    Jun 18, 2026
    8k filing
    3mo ago
    $PFE — PFIZER INC (PFE) — 8-K filing
    →
    May 5, 2026
    8k filing
    4mo ago
    $PFE — PFIZER INC (PFE) — 8-K filing
    →
    May 5, 2026
    earnings
    4mo ago
    PFIZER INC earnings
    PFIZER INC
    →
    $PFE28.45-1.25%
    $PFE28.45-1.25%
    $PFE28.45-1.25%
    $PFE28.45-1.25%